Abstract:OBJECTIVES:To investigate the methodology of diversified advanced image-guided stereotactic biopsy for the brain lesions, and its diagnostic significance and experience in nervous system diseases.METHODS:Retrospectively reviewed 1187 cases of brain lesions underwent image-guided stereotactic biopsy from December 1987 to January 2009. There were 694 male (58.5%) and 493 female (41.5%) patients, aged from 1 to 85 years (average 39.7 years). There were 607 cases in CT-guided, including positron emission computed tomography (PET) guided stereotactic biopsy; 580 cases in MRI-guided, including proton magnetic resonance spectroscopy ((1)H-MRS) guided stereotactic biopsy. Routine frame was used in 726 cases and frameless stereotactic biopsy in 461 cases, including neuroendoscopic biopsy in 28 cases, guided by computer assisted surgery (CAS) computer-assistant robot. In the early 450 cases, CT/MRI images films were employed to measure the coordinates of the target by hand, while in the late 737 cases, computer-assistant planning software rebuilt the CT/MRI images and figured out the optimal neurosurgical path for biopsy.RESULTS:The positive diagnosis rate of biopsy was 97.4%, 983 (82.8%) cases were diagnosed pathologically as brain tumors, and 173 (14.6%) cases as non-tumor diseases. The tumors mainly including neuroglioma, metastatic tumor, primary central nervous system lymphoma and germ cell tumors. In non-tumor diseases, mainly including multiple sclerosis, tumefactive demyelinating lesion, neurodegenerative disease, inflammation and parasite. The biopsy operation caused small hematoma without neurological deficits in 20 cases (1.7%), and caused large hematoma (> 10 ml) which need neurosurgical treatment (catheterization or craniotomy evacuation of hematoma) in 9 cases (0.8%). Hemorrhage associated with biopsy caused 3 cases (0.3%) death. There were no severe intracranial infection cases.CONCLUSIONS:The stereotactic biopsy with advanced image-guided technique represents a safe, reliable and minimally invasive method for pathological diagnosis of intracranial lesions. Moreover, the developments of biochemical imaging gives a new concept to the stereotactic biopsy.

Clinical study of minimally invasive CT-guided stereotactic surgery for brain lesions

Clinical Study of Minimally Invasive Stereotactic Biopsy for Brain Lesions

Cerebral Sterotaxic Surgery: Clinical Analysis of 58 Cases

Clinical Experience of Stereotactic Biopsy for the Brain Lesions

Treatment of Intracranial Lesions by Microsurgery Through Keyhole Approach in 73 Patients

Stereotactic microsurgery treatment on intracranial small lesions

Treatment of stereotactic microneurosurgery for intracranial lesions

Deep-seating Cerebral Lesions and Movement Disorders Treated by Stereotactic Operations (report of 32 Cases)

Application of stereotactic biopsy under MRI guidance to the diagnoses of intracranial lesions (report of 23 cases)

Clinical Research of Stereotactic Biopsy in Diagnosis of Multiple Intracranial Lesions

CT stereotactic assisted neuroendoscopic technique for intracranial lesions

Clinical Report of 5100 Cases with Stereotactic Operation

The clinical analysis of stereotactic intracerbral biopsy(report of 16 cases)

Clinical Reseach of Neuroendoscope Guided by Stereotaxis in Treatment of Brain Parenchymal Lesions

Stereotactic Biopsy for Lesions in Brainstem and Deep Brain: a Single-Center Experience of 72 Cases

Application of stereotactic biopsy for diagnosis of atypical neural diseases

GAMMA KNIFE COMBINED WITH STEREOTAXIC TECHNIQUE FOR BRAIN LESIONS

CT Guided Stereotactic Aspiration of Intracerebral Hematomas

CT-guided Percutaneous Minimal Invasion Surgery for Diagnosis and Treatment of Spinal Disease

[Magnetic Resonance Spectroscopy-Guided Stereotactic Biopsy for Brain Lesion].

Clinical application of CT-controlled stereotactic aspiration for intracerebral hematoma